Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trialJony van Hilst, Ferry A.L.M. Eskens, Dennis A. Wicherts et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 597
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancerAlessandro Leal, Victor E. Velculescu, Nicole C.T. van Grieken et al.|Nature Communications|2020Cited by 238
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P. Rovers, Aeilko H. Zwinderman, Checca Bakkers et al.|BMC Cancer|2019Cited by 111
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodiesSandra Heskamp, Hanneke W.M. van Laarhoven|International Journal of Cancer|2013Cited by 55
Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trialJonna K. van Vulpen, Anne M. May, Anouk E. Hiensch et al.|British journal of surgery|2021Cited by 42